Martin Zirngibl

Martin Zirngibl

Auto-generated profile, based on publicly available information

Martin Zirngibl

Cawthron Institute Nelson New Zealand

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2022 in Molecular Ecology Resources
Verified
Journal Article
Closed access
UAUlla von Ammon
Ulla von Ammon
XPXavier Pochon
Xavier Pochon
PCPaula Casanovas
Paula Casanovas
BTBranwen Trochel
Branwen Trochel
MZMartin Zirngibl
Martin Zirngibl
AZAnastasija Zaiko
Anastasija Zaiko

3 June 2021 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
DTDong-Jiunn Jeffery Truong
Dong-Jiunn Jeffery Truong
TPTeeradon Phlairaharn
Teeradon Phlairaharn
BEBianca Eßwein
Bianca Eßwein
CGChristoph Gruber
Christoph Gruber
DTDeniz Tümen
Deniz Tümen
GWGil Gregor Westmeyer
Gil Gregor Westmeyer
Expression of exon-specific isoforms from alternatively spliced mRNA is a fundamental mechanism that substantially expands the proteome of a cell. However, conventional methods to assess alternative splicing are either consumptive and work-intensive or do not quantify isoform expression longitudinally at the protein level. Here, we therefore developed an exon-specific isoform expression reporter system (EXSISERS), which non-invasively reports the translation of exon-containing isoforms of endogenous genes by scarlessly excising reporter proteins from the nascent polypeptide chain through highly efficient, intein-mediated protein splicing. We applied EXSISERS to quantify the inclusion of the disease-associated exon 10 in microtubule-associated protein tau (MAPT) in patient-derived induced pluripotent stem cells and screened Cas13-based RNA-targeting effectors for isoform specificity. We also coupled cell survival to the inclusion of exon 18b of FOXP1, which is involved in maintaining pluripotency of embryonic stem cells, and confirmed that MBNL1 is a dominant factor for exon 18b exclusion. EXSISERS enables non-disruptive and multimodal monitoring of exon-specific isoform expression with high sensitivity and cellular resolution, and empowers high-throughput screening of exon-specific therapeutic interventions.

5 July 2023 in New Zealand Journal of Marine and Freshwater Research
Verified
Journal Article
Open access
CBCamille G. Baettig
Camille G. Baettig
ABAndrew Barrick
Andrew Barrick
MZMartin Zirngibl
Martin Zirngibl
GLGavin Lear
Gavin Lear
KSKirsty F. Smith
Kirsty F. Smith
Louis TremblayLouis Tremblay
Louis Tremblay
Globally, there is a move towards using local, native species for ecotoxicological risk assessments. Anthropogenic stressors from urban, agricultural, and industrial activities can impact the health of receiving ecosystems. Biomarkers can provide valuable insights as early warning signals of the potential environmental impacts of stressors. The aim of this study was to develop biomarkers in the green‐lipped mussel ( Perna canaliculus ), a potential bioindicator of environmental health for coastal marine ecosystems in New Zealand. Reverse transcription quantitative polymerase chain reaction (RT‐qPCR) assays targeting the expression of genes involved in oxidative stress, xenobiotic transfer, membrane transportation, cellular and DNA response/repair, and endocrine disruption were developed and validated for P. canaliculus . We found significant modulation of genes associated with oxidative stress, xenobiotic transfer, membrane transport, endocrine disruption, and genotoxicity in P. canaliculus following 48‐hour exposures to copper and benzo[α]pyrene. These results demonstrate the potential of P. canaliculus as a bioindicator species for environmental risk assessment. The gene expression assays showed potential as early indicators of exposure to the chemicals tested but require additional validation to assess their ability to predict effects at higher levels of biological organisation.

26 October 2026 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
SBStefan Berghoff
Stefan Berghoff
LSLena Spieth
Lena Spieth
SVSimona Vitale
Simona Vitale
LSLennart Schlaphoff
Lennart Schlaphoff
MZMartin Zirngibl
Martin Zirngibl
MSMikael Simons
Mikael Simons
Dysfunctional immune responses impair remyelination and contribute to neurodegeneration. While immune and metabolic responses to acute myelin injury are well characterized, myeloid cell adaptations to chronic myelin damage remain poorly understood. Here we performed a comparative analysis of genetic and toxic mouse models of acute and chronic demyelination, which identified a distinct microglial state associated with chronic demyelination, characterized by sustained pro-inflammatory activation, lysosomal lipid sequestration and reduced lipid droplet formation. Transcriptomics profiling further revealed a metabolic program marked by upregulated cholesterol synthesis and diminished sterol efflux. Treatment with a desmosterol mimetic possessing 24-dehydrocholesterol reductase inhibitor activity reversed this microglial state, attenuated pro-inflammatory signaling (including C-C Motif Chemokine Ligand 4 expression), reduced myelin damage and improved motor performance in a mouse model of leukodystrophy. Our findings uncover a pro-inflammatory microglial state characterized by lysosomal dysfunction and increased myelin reactivity, highlighting a novel therapeutic target for chronic demyelinating disorders.